Capital Flow Monitor · Sponsors · CIK 1993469
AN Venture Partners I, LP
548 Market St., Suite 16299, San Francisco, CA, 94104-5401 · (650) 291-9747
Pooled Investment Fund / Venture Capital Fund · Limited Partnership· inc. CAYMAN ISLANDS true 2023
Fit score
—
Offering
$197.0M
Sold
$197.0M
% sold
100.0%
Investors
22
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-07-30 | D/A ·current | 506(b) | $197.0M | $197.0M | 100.0% | 22 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- n/a ANV GP I, LP — Director, San Francisco, CA
-
Ken Horne — Director, San Francisco, CA
2 other raises
- Imbria Pharmaceuticals, Inc. $66.7M of $144.2M · 46.3%
- Pahr Therapeutics, Inc. $4.7M of $14.0M · 33.3%
- n/a ANV Management, LLC — Director, San Francisco, CA
- n/a ANV GP I, LLC — Director, San Francisco, CA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.